George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.30
Bid: 82.50
Ask: 82.80
Change: 2.70 (3.39%)
Spread: 0.30 (0.364%)
Open: 79.20
High: 84.00
Low: 79.20
Prev. Close: 79.60
CHRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

7 Feb 2023 16:26

RNS Number : 2134P
Chrysalis Investments Limited
07 February 2023
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to The European Union Withdrawal Act 2018, as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

7 February 2023

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Portfolio Update

 

 

 

The Company can today announce that, subject to usual closing conditions, it has agreed to purchase £20 million of equity in Starling Bank ("Starling") via a secondary market transaction led by an existing, third-party shareholder in Starling.

The Company's Investment Adviser is optimistic about the prospects for Starling and believes this transaction will generate future value for Chrysalis shareholders.

On the 1 February 2023, the Company's Quarterly NAV Announcement detailed a gross cash position as of 30 January 2023 of approximately £69 million and a total liquidity position (including the listed position in Wise plc) of approximately £81 million. Assuming the Starling transaction closes, the Company's gross cash and total liquidity positions would both be reduced by £20 million, and Starling would account for approximately 15% of the portfolio including gross cash, versus approximately 12% as of 30 January 2023.

At the recent Capital Markets Day the Investment Adviser referred to a potential follow-on commitment to fund the portfolio of approximately £20 million. For clarity, this secondary transaction did not form part of this analysis.

If, following Completion, the Company's independent Valuation Committee recommends that the Board apply the "price of recent investment" approach to the Company's holding in Starling this would result in a modest uplift in the Company's NAV per share compared with the 31 December 2022 calculation.

 

 

-ENDS-

 

 

 

 

 

For further information, please contact

 

Media

Montfort Communications

Charlotte McMullen / Toto Reissland /

Lesley Kezhu Wang

 

 

 

 

 

 

+44 (0) 7976 098 139

chrysalis@montfort.london

 

 

Jupiter Asset Management:

James Simpson

 

+44 (0) 20 3817 1696

Liberum:

Chris Clarke / Darren Vickers / Owen Matthews

 

+44 (0) 20 3100 2000

Numis:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFLFFRFEIDIIV
Date   Source Headline
22nd Apr 20247:43 amRNSUpdate on claim against Revolution Beauty GroupPLC
15th Mar 20243:05 pmRNSResult of AGM & EGM
14th Mar 202412:28 pmRNSHolding(s) in Company
13th Mar 202411:36 amRNSHolding(s) in Company
11th Mar 20243:21 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSPortfolio Update
1st Mar 20243:01 pmRNSHolding(s) in Company
29th Feb 20249:48 amRNSHolding(s) in Company
8th Feb 20242:52 pmRNSUpdate from QuotedData
31st Jan 20244:46 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSQuarterly NAV Announcement and Trading Update
29th Jan 20247:00 amRNSNotice of AGM and Notice of EGM
29th Jan 20247:00 amRNSAnnual Results
12th Dec 20231:17 pmRNSHolding(s) in Company
11th Dec 202311:25 amRNSHolding(s) in Company
5th Dec 20232:14 pmRNSPortfolio Update
4th Dec 20233:32 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSInvestment Management Arrangements Update
30th Oct 20237:00 amRNSQuarterly NAV Announcement and Trading Update
13th Oct 20237:30 amRNSShareholder Update and Consultation
25th Sep 202310:09 amRNSHolding(s) in Company
13th Sep 20233:44 pmRNSHolding(s) in Company
11th Sep 20235:03 pmRNSHolding(s) in Company
7th Sep 20234:07 pmRNSHolding(s) in Company
21st Aug 202312:17 pmRNSHoldings in Company
31st Jul 20237:00 amRNSQuarterly NAV Announcement and Trading Update
27th Jul 20234:37 pmRNSUpdate from QuotedData
27th Jun 20237:00 amRNSInterim Results
13th Jun 202310:20 amRNSHolding(s) in Company
9th Jun 202312:06 pmRNSHolding(s) in Company
1st Jun 20233:10 pmRNSPortfolio Update
25th May 20239:14 amRNSPortfolio Update
15th May 20237:00 amRNSPortfolio Update
4th May 202310:00 amRNSQuarterly NAV Announcement and Trading Update
19th Apr 20233:16 pmRNSChange of Registered Office
21st Mar 20235:14 pmRNSResult of AGM
1st Mar 20233:15 pmRNSNotice of AGM
10th Feb 202310:34 amRNSHolding(s) in Company
7th Feb 20234:26 pmRNSPortfolio Update
1st Feb 20237:00 amRNSQuarterly NAV Announcement and Trading Update
31st Jan 20237:00 amRNSAnnual Results
6th Jan 20233:20 pmRNSHolding(s) in Company
15th Dec 20221:17 pmRNSHolding(s) in Company
30th Nov 20227:30 amRNSCapital Markets Event
30th Nov 20227:00 amRNSUpdate on Performance Fee Arrangements
25th Nov 202212:18 pmRNSPortfolio Update
21st Nov 20228:30 amRNSQuarterly NAV Announcement and Trading Update
21st Nov 20227:00 amRNSQuarterly NAV Announcement and Trading Update
21st Sep 20222:47 pmRNSHolding(s) in Company
9th Sep 202212:36 pmRNSResearch from QuotedData

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.